Nuclear Medicine and Biology
Volume 34, Issue 7 , Pages 737-742 , October 2007

Clinical use of FDG PET

  • Carl K. Hoh

      Affiliations

    • Corresponding Author InformationTel.: +1 619 543 6632; fax: +1 619 543 1975.

Received 21 May 2007 ,Revised 28 June 2007 ,Accepted 2 July 2007.

References 

  1. Ido T, Wan CN, Casella V, Fowler JS, Wolf AP, Reivich M, et al. Labeled 2-deoxy-d-glucose analogs: 18F-labeled 2-deoxy-2-fluoro-d-glucose, 2-deoxy-2-fluoro-d-mannose and 14C-2-deoxy-2-fluoro-d-glucose. J Label Compd Radiopharm. 1978;24:174–183
  2. Phelps ME, Hoffman EJ, Mullani NA, Ter-Pogossian MM. Application of annihilation co-incidence detection to transaxial reconstruction tomography. J Nucl Med. 1975;16:210–224
  3. Kety SS, Schmidt CF. The nitrous oxide method for the quantitative determination of the cerebral blood flow in man: theory, procedure, and normal values. J Clin Invest. 1948;27:476–483
  4. Dahlbom M, Hoffman EJ, Hoh CK, Schiepers C, Rosenqvist G, Hawkins RA, et al. Whole-body positron emission tomography: part I. Methods and performance characteristics. J Nucl Med. 1992;33:1191–1199
  5. Hoh CK, Hawkins RA, Glaspy JA, Dahlbom M, Tse NY, Hoffman EJ, et al. Cancer detection with whole-body PET using 2-[18F]fluoro-2-deoxy-d-glucose. J Comput Assist Tomogr. 1993;17:582–589
  6. Vansteenkiste JF, Stroobants SS. PET scan in lung cancer: current recommendations and innovation. J Thorac Oncol. 2006;1:71–73
  7. Gupta NC, Maloof J, Gunel E. Probability of malignancy in solitary pulmonary nodules using fluorine-18-FDG and PET. J Nucl Med. 1996;37:943–948
  8. Lowe VJ, Fletcher JW, Gobar L, et al. Prospective investigation of positron emission tomography in lung nodules. J Clin Oncol. 1998;16:1075–1084
  9. Pelosi E, Deandreis D. The role of 18F-fluoro-deoxy-glucose positron emission tomography (FDG-PET) in the management of patients with colorectal cancer. Eur J Surg Oncol. 2007;33:1–6
  10. Mikhaeel NG. Use of FDG-PET to monitor response to chemotherapy and radiotherapy in patients with lymphoma. Eur J Nucl Med Mol Imaging. 2006;33:22–26
  11. Macapinlac HA. FDG PET and PET/CT imaging in lymphoma and melanoma. Cancer J. 2004;10:262–270
  12. Hutchings M, Eigtved AI, Specht L. FDG-PET in the clinical management of Hodgkin lymphoma. Crit Rev Oncol Hematol. 2004;52:19–32
  13. Doot RK, Dunnwald LK, Schubert EK, Muzi M, Petersen LM, Kinahan PE, et al. Dynamic and static approaches to quantifying 18F-FDG uptake for measuring cancer response to therapy, including the effect of granulocyte CSF. J Nucl Med. 2007;48:920–925
  14. Lee KS, Marwick TH, Cook SA, Go RT, Fix JS, James KB, et al. Prognosis of patients with left ventricular dysfunction, with and without viable myocardium after myocardial infarction. Relative efficacy of medical therapy and revascularization. Circulation. 1994;90:2687–2694
  15. Machac J. Cardiac positron emission tomography imaging. Semin Nucl Med. 2005;35:17–36
  16. Bax JJ, Poldermans D, Elhendy A, Boersma E, Rahimtoola SH. Sensitivity, specificity, and predictive accuracies of various noninvasive techniques for detecting hibernating myocardium. Curr Probl Cardiol. 2001;26:142–186
  17. Bax JJ, Van der Wall EE. Viability assessment: nuclear imaging vs dobutamine echocardiography. Int J Cardiovasc Imaging. 2003;19:529–531
  18. Selvanayagam JB, Kardos A, Francis JM, Wiesmann F, Petersen SE, Taggart DP, et al. Value of delayed-enhancement cardiovascular magnetic resonance imaging in predicting myocardial viability after surgical revascularization. Circulation. 2004;110:1535–1541
  19. Herholz K, Heiss WD. Positron emission tomography in clinical neurology. Mol Imaging Biol. 2004;6:239–269
  20. Stefan H, Schneider S, Feistel H, Pawlik G, Schuler P, Abraham-Fuchs K, et al. Ictal and interictal activity in partial epilepsy recorded with multichannel magnetoelectroencephalography: correlation of electroencephalography/electrocorticography, magnetic resonance imaging, single photon emission computed tomography, and positron emission tomography findings. Epilepsia. 1992;33:874–887
  21. Pataraia E, Simos PG, Castillo EM, Billingsley RL, Sarkari S, Wheless JW, et al. Does magnetoencephalography add to scalp video-EEG as a diagnostic tool in epilepsy surgery?. Neurology. 2004;62:943–948
  22. Silverman DHS, Small GW, Chang CY, Lu CS, Kung de Aburto MA, Chen W, et al. Positron emission tomography in evaluation of dementia, regional brain metabolism and long-term outcome. JAMA. 2001;286:2120–2127
  23. Masdeu JC, Zubieta JL, Arbizu J. Neuroimaging as a marker of the onset and progression of Alzheimer's disease. J Neurol Sci. 2005;236:55–64

PII: S0969-8051(07)00180-1

doi: 10.1016/j.nucmedbio.2007.07.001

Nuclear Medicine and Biology
Volume 34, Issue 7 , Pages 737-742 , October 2007

Article Tools

* Image Usage & Resolution